San Jose BioCenter, Thursday Afternoon, March 15, 2012
Topic: “Who is Catalyzing Life Science Startups? New Opportunities for Funding”
Panelists:
• Wende Hutton, General Partner, Canaan Partners
• Craig Muir, Partner, Third Rock Ventures
• Jeff Calcagno, Senior Director, Emerging Technologies, Corporate Office of Science & Technology (COSAT), Johnson & Johnson
• [Lead Facilitator] Scott M. Iyama, Corporate Senior Associate, Orrick, Herrington & Sutcliffe LLP
Date and Time: March 15, 2012 / 3:00pm - 6:30pm
Location: Orrick, Herrington & Sutcliffe LLP, 1000 Marsh Road, Building 1100, Menlo Park, CA 94025-1015
Cost: General-$60; Partner-$50
Register at http://money2012.eventbrite.com/
Topic Description
It's becoming a more frequent occurrence that investors and drugmakers are getting involved in building companies from the ground-up. Third Rock Ventures has a renowned model for "launching" new ventures and Johnson & Johnson's Corporate Office of Science and Technology (COSAT) program sets out to "identify and nurture promising technologies." There are also a few firms that have been successful in raising new funds, most recently Canaan Partners, a Menlo Park based firm raised $600M, a third of which will be dedicated to healthcare companies. The BioCenter and Orrick are therefore bringing together key players involved in building and funding start-ups for a panel discussion.
